{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:55:34Z","timestamp":1775458534234,"version":"3.50.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"35","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,29]]},"abstract":"<jats:p>\n                    An increasing body of research indicates an association between lipid-lowering medications and sensorineural hearing loss (SNHL), although there is still controversy. Therefore, the aim of this study is to investigate the genetic correlation between different lipid-lowering therapeutic gene targets and SNHL. The genetic association between lipids, lipid-lowering drug target genes, and SNHL was analyzed using a 2-sample Mendelian randomization approach. The exposures included 5 circulating lipid levels (triglycerides, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, apolipoprotein A-I, and apolipoprotein B) and 10 target genes simulating the effects of lipid-lowering drugs (HMGCR, PCSK9, Niemann-Pick C1-like 1 [NPC1L1], LDLR, APOB, CETP, LPL, ANGPTL3, APOC3, and PPARA). Summary data from a large-scale genome-wide association study on SNHL from the Finnish database were used as the outcome. The inverse variance-weighted method was employed as the primary approach, with sensitivity tests conducted to evaluate heterogeneity and pleiotropy in the results. The genetic prediction of lipid levels was not significantly associated with SSNL. However, genetic proxies for lowering low-density lipoprotein cholesterol, specifically variants in NPC1L1 (OR\u2005=\u20051.943 [95% CI 1.116\u20133.383];\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.018) and LDL receptor (LDLR) (OR\u2005=\u20051.279 [95% CI 1.107\u20131.477];\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001), were associated with an increased risk of SNHL. Similarly, a genetic proxy for lowering triglycerides, the apoprotein C-III (APOC3) variant (OR\u2005=\u20051.174 [95% CI 1.054\u20131.307];\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.003), was associated with an increased risk of SNHL. After Bonferroni correction, the genetic variants for LDLR and APOC3 remained significantly associated with an increased risk of SNHL, while the association with the NPC1L1 lipid-lowering variant was no longer significant. This study suggests that lipid-lowering medications potentially have a causal impact on increasing the risk of SNHL through the LDLR and APOC3 pathways. LDLR and APOC3 show potential as candidate drug targets for the prevention of SNHL. However, the results of the study and the potential mechanism of action require further experimental validation and evaluation.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000044174","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T19:01:23Z","timestamp":1756494083000},"page":"e44174","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the relationship between lipid-lowering drug target genes and sensorineural hearing loss by Mendelian randomization"],"prefix":"10.1097","volume":"104","author":[{"given":"Yan","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology, Pengzhou Hospital of Traditional Chinese Medicine, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-Fei","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Pengzhou Hospital of Traditional Chinese Medicine, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1443-2695","authenticated-orcid":false,"given":"Kun-Lin","family":"Pu","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Pengzhou Hospital of Traditional Chinese Medicine, Chengdu, Sichuan, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20260406","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.3390\/ijms22115647","article-title":"Molecular mechanisms of sensorineural hearing loss and development of inner ear therapeutics.","volume":"22","author":"Vlajkovic","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R2-20260406","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fncel.2019.00323","article-title":"Gene therapy for human sensorineural hearing loss.","volume":"13","author":"Ren","year":"2019","journal-title":"Front Cell Neurosci"},{"key":"R3-20260406","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/coa.13756","article-title":"The inaugural world report on hearing: from barriers to a platform for change.","volume":"46","author":"McMahon","year":"2021","journal-title":"Clin Otolaryngol"},{"key":"R4-20260406","doi-asserted-by":"crossref","first-page":"1230125","DOI":"10.3389\/fmicb.2023.1230125","article-title":"Association between gut microbiota and sensorineural hearing loss: a Mendelian randomization study.","volume":"14","author":"Yin","year":"2023","journal-title":"Front Microbiol"},{"key":"R5-20260406","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/MAO.0000000000001427","article-title":"Emerging therapies for sensorineural hearing loss.","volume":"38","author":"Crowson","year":"2017","journal-title":"Otol Neurotol"},{"key":"R6-20260406","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archotol.129.10.1041","article-title":"The 5-year incidence and progression of hearing loss: the epidemiology of hearing loss study.","volume":"129","author":"Cruickshanks","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R7-20260406","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.3390\/nu11071668","article-title":"Can nutritional intervention for obesity and comorbidities slow down age-related hearing impairment?","volume":"11","author":"Tang","year":"2019","journal-title":"Nutrients"},{"key":"R8-20260406","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s12070-023-03657-w","article-title":"A study of relationship between serum lipids and sensorineural hearing loss.","volume":"75","author":"Silky","year":"2023","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"Suppl 1","key":"R9-20260406","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12070-022-03328-2","article-title":"Relationship between lipid profile and sensorineural hearing loss: an institution based study.","volume":"75","author":"Sharma","year":"2023","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"R10-20260406","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3390\/ph14111076","article-title":"Association between statin use and sensorineural hearing loss in type 2 diabetic patients: a hospital-based study.","volume":"14","author":"Han","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"R11-20260406","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/01.mao.0000271673.33683.7b","article-title":"Effect of atorvastatin on progression of sensorineural hearing loss and tinnitus in the elderly: results of a prospective, randomized, double-blind clinical trial.","volume":"28","author":"Olzowy","year":"2007","journal-title":"Otol Neurotol"},{"key":"R12-20260406","doi-asserted-by":"crossref","first-page":"1164387","DOI":"10.3389\/fendo.2023.1164387","article-title":"Association of antihypertensive drugs with fracture and bone mineral density: a comprehensive drug-target Mendelian randomization study.","volume":"14","author":"Huang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R13-20260406","doi-asserted-by":"crossref","first-page":"1258018","DOI":"10.3389\/fphar.2023.1258018","article-title":"Association of lipid lowering drugs and the risk of systemic lupus erythematosus: a drug target Mendelian randomization.","volume":"14","author":"Wu","year":"2023","journal-title":"Front Pharmacol"},{"key":"R14-20260406","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamadermatol.2022.6051","article-title":"Association of lipid-lowering drugs with risk of psoriasis: a mendelian randomization study.","volume":"159","author":"Zhao","year":"2023","journal-title":"JAMA Dermatol"},{"key":"R15-20260406","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.jacc.2022.07.006","article-title":"2022 ACC expert consensus decision pathway on the role of nonstatin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a report of the American College of Cardiology solution set oversight committee.","volume":"80","author":"Lloyd-Jones","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R16-20260406","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s12944-023-01983-0","article-title":"Genetic insights into the association of statin and newer nonstatin drug target genes with human longevity: a Mendelian randomization analysis.","volume":"22","author":"Chen","year":"2023","journal-title":"Lipids Health Dis"},{"key":"R17-20260406","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R18-20260406","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R19-20260406","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s10194-023-01633-x","article-title":"Lipids, lipid-modifying drug target genes and migraine: a Mendelian randomization study.","volume":"24","author":"Bi","year":"2023","journal-title":"J Headache Pain"},{"key":"R20-20260406","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41569-018-0098-5","article-title":"Safety and efficacy of statin therapy.","volume":"15","author":"Adhyaru","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"R21-20260406","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system.","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ Res"},{"key":"R22-20260406","first-page":"CD003160","article-title":"Statins for the prevention of dementia.","volume":"2016","author":"McGuinness","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"R23-20260406","doi-asserted-by":"crossref","first-page":"14388","DOI":"10.1038\/s41598-021-93916-z","article-title":"Association between statin medication and hearing impairment in a national health screening cohort.","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"R24-20260406","first-page":"133","article-title":"Effect of statins on hearing function and subjective tinnitus in hyperlipidemic patients.","volume":"57","author":"Y\u00fccel","year":"2019","journal-title":"Rom J Intern Med"},{"key":"R25-20260406","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3945\/jn.111.138610","article-title":"Dietary intake of cholesterol is positively associated and use of cholesterol-lowering medication is negatively associated with prevalent age-related hearing loss.","volume":"141","author":"Gopinath","year":"2011","journal-title":"J Nutr"},{"key":"R26-20260406","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000236014","article-title":"Effects of simvastatin on plasma lipoproteins and hearing loss in apolipoprotein E gene-deficient mice.","volume":"71","author":"Cai","year":"2009","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"R27-20260406","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/0194599820969630","article-title":"Association between sudden sensorineural hearing loss and history of statin use: a nested case\u2013control study.","volume":"165","author":"Kim","year":"2021","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R28-20260406","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1002\/PHAR.1040","article-title":"Irreversible atorvastatin-associated hearing loss.","volume":"32","author":"Liu","year":"2012","journal-title":"Pharmacotherapy"},{"key":"R29-20260406","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.atherosclerosis.2012.05.014","article-title":"The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.","volume":"223","author":"Tich\u00fd","year":"2012","journal-title":"Atherosclerosis"},{"key":"R30-20260406","doi-asserted-by":"crossref","first-page":"108311","DOI":"10.1016\/j.heares.2021.108311","article-title":"LDLR expression in the cochlea suggests a role in endolymph homeostasis and cochlear amplification.","volume":"409","author":"Saume","year":"2021","journal-title":"Hear Res"},{"key":"R31-20260406","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1515\/CCLM.2002.171","article-title":"Gene polymorphism and coronary risk factors in Indian population.","volume":"40","author":"Ashavaid","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"R32-20260406","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1080\/00016480801901626","article-title":"A clinical study of microcirculatory disturbance in Chinese patients with sudden deafness.","volume":"128","author":"Lu","year":"2008","journal-title":"Acta Otolaryngol"},{"key":"R33-20260406","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3389\/fendo.2020.00474","article-title":"The roles of ApoC-III on the metabolism of triglyceride-rich lipoproteins in humans.","volume":"11","author":"Bor\u00e9n","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R34-20260406","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/ATVBAHA.118.311476","article-title":"Effects of APOC3 heterozygous deficiency on plasma lipid and lipoprotein metabolism.","volume":"39","author":"Reyes-Soffer","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R35-20260406","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12944-021-01531-8","article-title":"APOC3 genetic variation, serum triglycerides, and risk of coronary artery disease in Asian Indians, Europeans, and other ethnic groups.","volume":"20","author":"Goyal","year":"2021","journal-title":"Lipids Health Dis"},{"key":"R36-20260406","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/cvr\/cvv192","article-title":"Aggravated restenosis and atherogenesis in ApoCIII transgenic mice but lack of protection in ApoCIII knockouts: the effect of authentic triglyceride-rich lipoproteins with and without ApoCIII.","volume":"107","author":"Li","year":"2015","journal-title":"Cardiovasc Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T06:01:01Z","timestamp":1775455261000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000044174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":36,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044174","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"2024-04-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-31","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}